Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
To see how well Naftin 1% cream works when applied once daily to the affected area. The
results will be compared to those using a placebo cream, which is a cream with no active
ingredient. Safety will also be measured.
Phase:
Phase 3
Details
Lead Sponsor:
Merz North America, Inc. Merz Pharmaceuticals, LLC